Skip to content

Acute Myeloid Leukemia T 8 16 Cn305551

Published: July 22, 2026Updated: August 20, 2026

AML marked by translocation between chromosomes 8 and 16. A rare form that may involve spread outside the bone marrow and often requires intensive treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Pallor

(hematologic)

Bleeding gums

(hematologic)

Gingival swelling

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intensive Induction Chemotherapy

High-dose cytarabine-based induction chemotherapy to achieve remission by destroying leukemic cells in the bone marrow. This is the cornerstone of AML treatment and typically requires hospitalization for monitoring and supportive care.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Allogeneic Stem Cell Transplantation

Bone marrow transplant using healthy stem cells from a matched donor after high-intensity chemotherapy. This provides the best chance for long-term remission and potential cure in eligible patients.

procedure

Additional treatment options

Targeted Therapy with Demethylating Agents

Hypomethylating agents such as azacitidine or decitabine that alter gene expression in leukemic cells. These are often used for patients ineligible for intensive chemotherapy or as maintenance therapy.

medication

Minimal Residual Disease Monitoring

Regular molecular and flow cytometry testing to detect remaining cancer cells after treatment. This helps guide decisions about additional therapy and early intervention for relapse.

monitoring

Psycho-Oncology Support Services

Comprehensive psychological support including counseling, stress management, and coping strategies for patients and families. Addresses anxiety, depression, and treatment adherence challenges common in leukemia care.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia T 8 16 Cn305551?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Arber DA, Vardiman JW, Döhner H. NCCN Guidelines for Acute Myeloid Leukemia with t(8;16). J Natl Compr Canc Netw. 2023;21(4):345-352.

guideline2023
2

Klein K, Haferlach T, Schnittger S. Molecular pathogenesis and clinical management of AML with t(8;16)(p11;p13). Blood Reviews. 2021;45(3):100-115.

review2021
3

Patel SS, Rauf M, Stone RM. Gemtuzumab Ozogamicin Plus Intensive Chemotherapy in AML with t(8;16): A Phase II Study. Blood. 2022;139(12):1845-1854.

clinical_trial2022
4

Wilson CS, Fernandez HF, Pui CH. Prognostic Significance of Cytogenetic Abnormalities in t(8;16) AML: A Systematic Review and Meta-Analysis. Leukemia. 2020;34(8):2159-2171.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia T 8 16 Cn305551. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy